On May 21, 2014, Jean-Jacques Bienaim tendered his resignation as a member of the Board of Directors of Portola Pharmaceuticals, Inc. effective June 30, 2014, and as a member and the chairperson of the Compensation Committee of the Board, effective immediately. Mr. Bienaim served as a Portola Director since September 2010. On May 27, 2014, the Board appointed John H. Johnson as chairperson of the Compensation Committee.
Portola Pharmaceuticals, Inc.
Equities
US7370101088
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+31.46% | 49.46B | |
+1.68% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.61% | 26.61B | |
-23.84% | 18.64B | |
+8.02% | 13.16B | |
+30.78% | 12.55B | |
+24.03% | 12.1B |